While some studies indicate an association between high peripheral monocyte counts and increased CD8+ TIL (a positive prognostic indicator) [30], or lower risk of developing breast cancer [102], other cohorts displayed a clear clinical benefit from lower monocyte counts, either due to fewer CTC in blood [36] or prolonged disease-free survival [31,37,77]. Here, CD8A is linked to breast carcinoma.